- Trials with a EudraCT protocol (752)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
752 result(s) found.
Displaying page 1 of 38.
EudraCT Number: 2008-001687-37 | Sponsor Protocol Number: LEX/001/C | Start Date*: 2008-07-08 | |||||||||||
Sponsor Name:Novosis AG | |||||||||||||
Full Title: An open label, parallel group phase III clinical study in patients with prostate cancer to demonstrate the non-inferiority of a new Novosis Leuprorelin 10.72 mg implant versus the reference product... | |||||||||||||
Medical condition: Male patients with carcinoma of the prostate aged 18 years and more and suitable for hormonal manipulation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001128-30 | Sponsor Protocol Number: BIIT001 | Start Date*: 2008-05-07 |
Sponsor Name:SE Dept. of Psychiatry and Psychotherapy | ||
Full Title: EFFICACY OF SERTINDOLE AS COMPARED TO OLANZAPINE OR RISPERIDONE ON PREATTENTIONAL AND ATTENTION-DEPENDENT FUNCTIONS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA. A COGNITIVE AND FMRI STUDY. | ||
Medical condition: schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021361-69 | Sponsor Protocol Number: DC01/RUP/2/09 | Start Date*: 2010-09-13 | |||||||||||
Sponsor Name:J. Uriach y Compañía, S.A. | |||||||||||||
Full Title: A multicenter, open-label study to assess pharmacokinetics, efficacy, tolerability and safety of Rupatadine in paediatrics patients (2-5 years old) with allergic rhinitis. | |||||||||||||
Medical condition: Allergic Rhinitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019369-27 | Sponsor Protocol Number: ANX001-01 | Start Date*: 2010-07-23 | |||||||||||
Sponsor Name:Anxiofit Ltd. | |||||||||||||
Full Title: A Phase II randomized, double-blind, parallel-group, multi-site, placebo controlled fixed-dose study of Echinaceae angustifoliae root dry extract in 24 outpatients with generalized anxiety disorder... | |||||||||||||
Medical condition: Generalized Anxiety Disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001806-29 | Sponsor Protocol Number: P-AD237-005 | Start Date*: 2005-09-29 |
Sponsor Name:Arakis Ltd | ||
Full Title: A multi-center, randomized, double-blind, parallel group, placebo controlled study, including an additional open label tiotropium group, to assess the efficacy, safety and tolerability of differen... | ||
Medical condition: Chronic obstructive pulmonary disease (COPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004587-30 | Sponsor Protocol Number: GOS/002/C | Start Date*: 2006-11-04 |
Sponsor Name:NOVOSIS AG | ||
Full Title: An open label, parallel group, Phase III clinical study in patients with advanced prostate cancer suitable for hormonal manipulation to demonstrate the non-inferiority of a new three-month Novosis ... | ||
Medical condition: prostate cancer suitable for hormonal manipulation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000377-20 | Sponsor Protocol Number: VK5211-201 | Start Date*: 2016-05-27 | |||||||||||
Sponsor Name:Viking Therapeutics, Inc. | |||||||||||||
Full Title: A Phase II, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Multi-Center Study to Explore the Efficacy, Safety and Tolerability of VK5211 in Subjects with Acute Hip Fracture | |||||||||||||
Medical condition: Hip fracture | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003785-24 | Sponsor Protocol Number: C15-050TRAVEL | Start Date*: 2014-10-02 | |||||||||||
Sponsor Name:Uzsoki Utcai Kórház | |||||||||||||
Full Title: Treatment of pancreatic adenocarcinoma with the combinationof carboplatin and velparib | |||||||||||||
Medical condition: pancreatic adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011099-31 | Sponsor Protocol Number: 2125-201 | Start Date*: 2010-06-11 |
Sponsor Name:Idera Pharmaceuticals, Inc. | ||
Full Title: A Multi-center, Randomized, Double-blind, Comparator-controlled, Dose-escalation Safety Assessment Study of Combination Treatment with IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype... | ||
Medical condition: Naïve Hepatitis C | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001859-36 | Sponsor Protocol Number: PRS-2011-03 | Start Date*: 2011-07-07 |
Sponsor Name:Meditop Pharmaceuticals Co. Ltd. | ||
Full Title: Clinical study on the insulin sensitizing effect of multiple administration of Vition (Meditop) in healthy human volunteers (Pilot study) | ||
Medical condition: Low potassium and magnesium levels especially in chronic heart disease. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001791-19 | Sponsor Protocol Number: G300504 | Start Date*: 2011-09-22 | |||||||||||||||||||||
Sponsor Name:GTx, Inc. | |||||||||||||||||||||||
Full Title: Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients with Non-Small Cell Lung Cancer on First Line Platinum Plus a Taxane Chemotherapy | |||||||||||||||||||||||
Medical condition: Cachexia, muscle wasting in patients with Non-Small Cell Lung Cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: HU (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000442-21 | Sponsor Protocol Number: S320.2.002 | Start Date*: 2005-09-05 |
Sponsor Name:Solvay Pharmaceuticals GmbH | ||
Full Title: A randomized, placebo-controlled, double-blind, multi-center, parallel group, single dose study to evaluate cardiac hemodynamics and safety during right heart catheterization of three iv doses of S... | ||
Medical condition: Congestive Heart Failure (CHF) requiring diuretic treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005883-25 | Sponsor Protocol Number: Scil-MD05-C02 | Start Date*: 2007-04-25 | |||||||||||
Sponsor Name:Scil Technology GmbH | |||||||||||||
Full Title: Pilot Study on Safety and Explorative Efficacy of MD05 in Comparison with Open Flap Debridement in Patients Undergoing Periodontal Surgery to Treat Deep Intrabony Defects | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004825-26 | Sponsor Protocol Number: G200712 | Start Date*: 2013-01-25 | ||||||||||||||||
Sponsor Name:GTx, Inc. | ||||||||||||||||||
Full Title: Phase II, open label study of the effect of GTx-758 as secondary hormonal therapy on serum PSA and serum free testosterone levels in men with castration resistant prostate cancer maintained on and... | ||||||||||||||||||
Medical condition: Assessments of serum total testosterone, serum free testosterone, serum SHGB and serum PSA concentrations will be made. Bone turnover markers and the incidence and frequency of hot flashes will be ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000838-36 | Sponsor Protocol Number: PX104.1.7-201 | Start Date*: 2004-09-20 |
Sponsor Name:Pharmexa A/S | ||
Full Title: A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer | ||
Medical condition: Female patients with histologically proven metastatic or locally advanced breast cancer who have HER-2 overexpression in the primary tumour and/or a metastatic lesion. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005138-21 | Sponsor Protocol Number: TC-5619-23-CRD-003 | Start Date*: 2012-04-03 |
Sponsor Name:Targacept Inc. | ||
Full Title: A double-blind, placebo-controlled, multicenter, parallel group study to assess efficacy, safety and tolerability of TC-5619 as augmentation therapy to improve negative symptoms and cognition in ou... | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000015-10 | Sponsor Protocol Number: KL4-BPD-01 | Start Date*: 2005-07-29 |
Sponsor Name:Discovery Laboratoryies, INC | ||
Full Title: A Randomized, Double-blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of Surfaxinâ (lucinactant), in Very Low Birth Weight (VLBW) Infants at Risk for Developing Bronchopulmonary Dy... | ||
Medical condition: In VLBW premature infants who have been intubated and received surfactants for the prevention or treatment of respiratory distress syndrome (RDS) | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007759-15 | Sponsor Protocol Number: CO-200-102 | Start Date*: 2008-11-10 | |||||||||||
Sponsor Name:PEPTIMMUNE Inc | |||||||||||||
Full Title: The Effect of the Dose of PI-2301 on Safety, Tolerability, and Pharmacokinetics in Subjects with the Secondary Progressive Form of Multiple Sclerosis A double-blind, placebo-controlled, randomized,... | |||||||||||||
Medical condition: Patients with current diagnosis of SP-MS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004927-11 | Sponsor Protocol Number: INNO-206-P2-STS-01 | Start Date*: 2012-03-02 | |||||||||||
Sponsor Name:CytRx Corporation | |||||||||||||
Full Title: A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects with Metastatic, Locally A... | |||||||||||||
Medical condition: Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001267-23 | Sponsor Protocol Number: PAT13300CCD | Start Date*: 2013-06-19 | ||||||||||||||||
Sponsor Name:Pharma Patent Kft | ||||||||||||||||||
Full Title: Open label multicentric study to evalute the safety and efficacy of CitrokalciumD 300 mg/300 NE tablets in patients assessed deficiency for supplementation of calcium and vitamin D. | ||||||||||||||||||
Medical condition: Vitamin D and calcium deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.